Li, Haiyan
Wei, Yudong
Zhang, Shuang
Xu, Lin
Jiang, Jun
Qiu, Yanping
Mangin, Eric
Zhao, Xu Min
Xie, Shuang
Funding for this research was provided by:
Merck
Merck Sharp and Dohme
Article History
First Online: 20 August 2019
Compliance with Ethical Standards
:
: This study was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, MSD China, Beijing.
: Haiyan Li, Yudong Wei, Shuang Zhang, and Lin Xu have no conflicts that are directly relevant to the content of this article. Jun Jiang, Yanping Qiu, Shuang Xie, and Xu Min Zhao are employees of Merck Sharp & Dohme, Beijing, China. Eric Mangin is an employee of Merck & Co., Inc., Kenilworth, NJ, USA.
: The Independent Ethics Committee of Peking University Third Hospital reviewed and approved the protocol and applicable amendments. This trial was conducted in conformance with Good Clinical Practice standards and applicable country and/or local statutes and regulations regarding ethics committee review, informed consent, and the protection of human subjects participating in biomedical research. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All subjects provided written informed consent.
: The data sharing policy (including restrictions) of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, is available at ExternalRef removed. Requests for access to the clinical study data can be submitted through the EngageZone site or via e-mail to dataaccess@merck.com.
Free to read: This content has been made available to all.